Coveney Kevin Michael has filed 5 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 40198 shares of Enveric Biosciences, Inc. ($ENVB) on December 23, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 23, 2025 | Enveric Biosciences, Inc. | $ENVB | Coveney Kevin Michael | Chief Financial Officer | A | Common Stock | 40198 | $0.00 | 47,413.0000 | 596,978 | 557.14% | 6.73% |
| May 8, 2025 | Enveric Biosciences, Inc. | $ENVB | Coveney Kevin Michael | CHIEF FINANCIAL OFFICER | A | Common Stock | 74150 | $0.00 | 86,584.0000 | 2,471,656 | 596.35% | 3.00% |
| Oct. 9, 2024 | Enveric Biosciences, Inc. | $ENVB | Coveney Kevin Michael | CHIEF FINANCIAL OFFICER | A | Common Stock | 100000 | $0.00 | 186,500.0000 | 0 | 115.61% | 0.00% |
| Feb. 22, 2024 | Enveric Biosciences, Inc. | $ENVB | Coveney Kevin Michael | CHIEF FINANCIAL OFFICER | A | Common Stock | 60000 | $0.00 | 86,500.0000 | 0 | 226.42% | 0.00% |
| March 13, 2023 | Enveric Biosciences, Inc. | $ENVB | Coveney Kevin Michael | Chief Financial Officer | A | Common Stock | 26500 | $0.00 | 26,500.0000 | 0 | 9999.99% | 0.00% |